“Roche Continents” at the Salzburg Festival brings together young talent in arts and science

Basel/Salzburg, 23 July 2012

Roche supports concert series “Salzburg contemporary” at the Festival

Within the scope of the study workshop “Roche Continents” Roche invites for the sixth time 100 students from all across Europe to the Salzburg Festival. They will discover the role of innovation in arts and science during a varied program of workshops and discussions with experts.

Franz B. Humer, Chairman of the Board of Roche, said: “The impulse for new ideas comes when different worlds collide with each other. This holds true for innovation in business, as it does for art and culture. Supporting the exchange between young talents in science and art is just as embedded in the Roche DNA as is our commitment to culture.”

The concert series Salzburg contemporary with works of contemporary artists is an integral part of the program. The series is also financially supported by Roche, allowing subsidized admission prices.

Helga Rabl-Stadler, President of the Salzburg Festival, added: “It is wonderful to have a sponsor who continues to be inspired by new ideas in the arts. Roche supports projects that have and open outcome. Roche and the Festival know that risk is the forebear of success.”

About Roche Continents

Roche has a long tradition of supporting artistic and cultural projects. Roche Continents is a project that has grown from Roche’s partnership with the Salzburg Festival, where the company sponsors "Salzburg contemporary", a new series of concerts featuring the works of contemporary composers. Roche Continents is aimed at students and young scientists aged between 20 and 29 from across Europe. It enables them to experience performances of contemporary music and to discover the common ground of creativity in the arts and science. Participants meet other students from all parts of Europe to explore topics from the worlds of art and science. Together they attend performances of works by outstanding contemporary composers at the Salzburg Festival.

About the Salzburg Festival

The Salzburg Festival was founded in 1920. In the midst of the First World War, founding fathers Hugo von Hofmannsthal, Max Reinhardt, Richard Strauss, Alfred Roller and Franz Schalk determined to establish the Salzburg Festival with a view to reconciling the peoples of war-torn Europe.

From its inception, the festival was conceived of as a project to combat existential crisis and the erosion of values in modern society as well as the identity crisis affecting not only individuals but also entire nations.

For a short period of five to six weeks in the summer, the Salzburg Festival stages operatic, theatrical and orchestral performances of outstanding artistic merit against a backdrop of flawlessly preserved Baroque architecture which is itself a marvel.

The Salzburg Festival rightly enjoys a reputation for being the world’s largest and most prestigious festival, and not only in terms of the sheer number of performances, annual visitors and tickets offered for sale. Anyone who is anyone in the performing arts – conductors, directors, singers, actors and virtuosos of international repute – sets aside July and August for the rendezvous by the Salzach.

About Roche

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche’s personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2011, Roche had over 80,000 employees worldwide and invested over 8 billion Swiss francs in R&D. The Group posted sales of 42.5 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com.

All trademarks used or mentioned in this release are protected by law.